Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Hematology
•
Hemostasis/Thrombosis
•
Pulmonology
•
Pulmonary Vascular Disease
•
Pulmonary Embolus
How does your approach to subsegmental PE differ from segmental PE both diagnostically and therapeutically?
Related Questions
How do you manage concurrent nonlife-threatening hemoptysis and acute pulmonary embolism?
How would you manage symptomatic, bilateral subsegmental PE developed after long air travel?
How long post operatively do you wait before transitioning from parenteral anticoagulation to oral anticoagulants after pulmonary thromboendarterectomy for CTEPH?
Do you obtain an echocardiogram as a part of risk stratification in all patients hospitalized with an acute pulmonary embolism?
In which cases would you consider early transition to DOAC (within 72 hours) for hospitalized patients with intermediate or high risk PE?
How do you follow pulmonary embolism patients who have completed anticoagulation?
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
How would you counsel a female to male transgender patient regarding VTE risk with testosterone therapy, who has additional mild-moderate risk factors for thrombosis?
How would you manage superficial thrombophlebitis of the great saphenous vein involving the knee and calf?
Do you use direct oral anticoagulants to treat port-a-cath related VTE in patients with an active malignancy?
